Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Teva
Dow
Queensland Health
Medtronic
Cipla
Novartis
US Department of Justice
Express Scripts
Healthtrust

Generated: January 21, 2018

DrugPatentWatch Database Preview

CHIROCAINE Drug Profile

« Back to Dashboard

When do Chirocaine patents expire, and when can generic versions of Chirocaine launch?

Chirocaine is a drug marketed by Purdue Pharma Lp and is included in one NDA.

The generic ingredient in CHIROCAINE is levobupivacaine hydrochloride. Additional details are available on the levobupivacaine hydrochloride profile page.

US Patents and Regulatory Information for CHIROCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-001 Aug 5, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-002 Aug 5, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-003 Aug 5, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CHIROCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-001 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-002 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Purdue Pharma Lp CHIROCAINE levobupivacaine hydrochloride INJECTABLE;INJECTION 020997-003 Aug 5, 1999 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
Colorcon
Mallinckrodt
Healthtrust
Covington
Baxter
Teva
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot